LFWD Lifeward Ltd.

Nasdaq rewalk.com


$ 0.68 $ -0.03 (-3.8 %)    

Tuesday, 21-Oct-2025 14:06:31 EDT
QQQ $ 611.77 $ 0.24 (0.04 %)
DIA $ 470.33 $ 3.21 (0.69 %)
SPY $ 672.23 $ 0.74 (0.11 %)
TLT $ 92.01 $ 0.03 (0.03 %)
GLD $ 378.92 $ -7.65 (-1.98 %)
$ 0.7
$ 0.71
$ 0.68 x 200
$ 0.68 x 100
$ 0.68 - $ 0.71
$ 0.50 - $ 4.00
236,958
na
10.99M
$ 1.41
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 03-07-2025 01-01-1970 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 02-27-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-11-2023 06-30-2023 10-Q
10 05-11-2023 03-31-2023 10-Q
11 02-23-2023 12-31-2022 10-K
12 11-07-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-Q
14 05-13-2022 03-31-2022 10-Q
15 02-24-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-09-2021 06-30-2021 10-Q
18 05-11-2021 03-31-2021 10-Q
19 02-18-2021 12-31-2020 10-K
20 11-10-2020 09-30-2020 10-Q
21 08-12-2020 06-30-2020 10-Q
22 05-28-2020 03-31-2020 10-Q
23 02-20-2020 12-31-2019 10-K
24 11-13-2019 09-30-2019 10-Q
25 08-09-2019 06-30-2019 10-Q
26 05-08-2019 03-31-2019 10-Q
27 02-08-2019 12-31-2018 10-K
28 11-08-2018 09-30-2018 10-Q
29 08-14-2018 06-30-2018 10-Q
30 05-15-2018 03-31-2018 10-Q
31 03-08-2018 12-31-2017 10-K
32 11-02-2017 09-30-2017 10-Q
33 08-03-2017 06-30-2017 10-Q
34 05-04-2017 03-31-2017 10-Q
35 02-17-2017 12-31-2016 10-K
36 11-03-2016 09-30-2016 10-Q
37 08-04-2016 06-30-2016 10-Q
38 05-10-2016 03-31-2016 10-Q
39 02-29-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Medicare Advantage claim processed in less than thirty daysAdditional progress with traditional Medicare claim approvals has ac...

Core News & Articles

Lifeward Ltd., (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to...

Core News & Articles

https://sam.gov/opp/09d936af89b2496392773ea6302bda5c/view

Core News & Articles

Lifeward (NASDAQ:LFWD) lowers FY2025 sales outlook from $28.000 million-$30.000 million to $24.000 million-$26.000 million vs $...

Core News & Articles

Rewalk Robotics (NASDAQ:LFWD) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0...

Core News & Articles
Lifeward Names Almog Adar As CFO
08/13/2025 12:18:54

Core News & Articles

Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to ...

Core News & Articles

Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to ...

Core News & Articles

Lifeward (NASDAQ:LFWD) affirms FY2025 sales outlook from $28.00 million-$30.00 million to $28.00 million-$30.00 million vs $28....

Core News & Articles

Rewalk Robotics (NASDAQ:LFWD) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0...

Core News & Articles

Seventh generation of industry-leading personal exoskeleton is now available nationwide for individuals with spinal cord injury...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION